Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
Full Year 2023 GAAP Revenues of $1.147 billion Full Year 2023 GAAP net loss of $20 million and GAAP net loss per diluted share of $0.45 Full Year 2023 Non-GAAP EBITDA of $138 million and Non-GAAP net...
United States Randall Lipps Technical Services Revenues Central Pharmacy Dispensing Service Omnicell Inc B Program
Source: marketscreener.com